
Publication
Patenting biomarker-related AI / machine-learning innovations
Defining patent-eligible subject matter under 35 U.S.C. § 101 is an ongoing struggle for the United States Patent and Tr...
Publication
Defining patent-eligible subject matter under 35 U.S.C. § 101 is an ongoing struggle for the United States Patent and Tr...
Publication
Following a relatively promising start to the year for mergers and acquisitions (M&A) activity, the US tariff announceme...
The AI regulatory landscape is changing. As the landmark EU AI Act sweeps into force, businesses need to consider their ...
Publication
Defining patent-eligible subject matter under 35 U.S.C. § 101 is an ongoing struggle for the United States Patent and Tr...
Publication
Following a relatively promising start to the year for mergers and acquisitions (M&A) activity, the US tariff announceme...
© Norton Rose Fulbright LLP 2025